Neuroscience Education Institute

Quote for "exact phrases"

All Activities only Prescriber's Guide

Activity Type

Topic

With Credit only

Guest activities only

Sort order: Newest to oldest Alphabetical by title

Results 1 - 50 of 62

	Switching from Oral Risperidone to Risperidone Subcutaneous Switching and Deprescribing added 10/31/2025. CME credit is not available
	Switching from Oral Paliperidone to Paliperidone Palmitate (1M, Sustenna) Switching and Deprescribing added 10/31/2025. CME credit is not available
	Switching from Oral Paliperidone to Paliperidone Palmitate (1M, Erzofri) Switching and Deprescribing added 10/31/2025. CME credit is not available
	Switching from Oral Aripiprazole to Aripiprazole Monohydrate Switching and Deprescribing added 10/31/2025. CME credit is not available
	Switching from Oral Aripiprazole to Aripiprazole Lauroxil Switching and Deprescribing added 10/31/2025. CME credit is not available
	Long-Acting Injectable (LAI) Antipsychotic Formulations Medication Tips and Pearls added 10/31/2025. CME credit is not available
	Switching from Oral Haloperidol to Haloperidol Decanoate Switching and Deprescribing added 10/31/2025. CME credit is not available
	Choosing Amongst the Long-Acting Injectable Antipsychotics: An Evidence-Based Pragmatic Guide CNS Spectrums added 09/29/2025. CME credit is available
	SSRIs and SNRIs Lower Relapse in Clozapine Treated Schizophrenia This Month in Psychpharmacology added 09/26/2025. CME credit is not available
	Clozapine Shows Greater Benefit in Schizoaffective Disorder This Month in Psychpharmacology added 08/23/2025. CME credit is not available
	You and I and an LAI: Benefits, Early Adoption, and Options for Patients With Serious Mental Illness Encore Presentation added 08/01/2025. CME credit is available
	Names Will Never Hurt Me? “Antipsychotics” in the Treatment of Mood Disorders Encore Presentation added 06/06/2025. CME credit is available
	Exciting Advances in Our Understanding of Glutamatergic Neurotransmission in Mental Illness Encore Presentation added 06/05/2025. CME credit is available
	Outside the Box: Upstream Muscarinic Modulation of Downstream Dopamine Encore Presentation added 06/05/2025. CME credit is available
	Valbenazine in Elderly Adults with Tardive Dyskinesia This Month in Psychpharmacology added 06/04/2025. CME credit is not available
	LAI Pearls: It's All About Kinetics and Collaboration Encore Presentation added 05/02/2025. CME credit is available
	Population Study Reveals Most Effective Antipsychotic Strategies for First-Episode Schizophrenia This Month in Psychpharmacology added 02/16/2025. CME credit is not available
	Breaking the Cycle: Optimizing Treatment Strategies for Serious Mental Illness in Order to Prevent Criminal Institutionalization Encore Presentation added 12/27/2024. CME credit is available
	Antipsychotic Polypharmacy on the Rise This Month in Psychpharmacology added 12/17/2024. CME credit is not available
	Mortality Risk In Long-Acting Injectable Versus Oral Antipsychotics In Schizophrenia This Month in Psychpharmacology added 09/12/2024. CME credit is not available
	Long-Acting Injectable Antipsychotics in the Geriatric Population This Month in Psychpharmacology added 08/12/2024. CME credit is not available
	Long-Term Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia This Month in Psychpharmacology added 07/31/2024. CME credit is not available
	Long-Acting Injectables Treatment and Testing Guides added 07/22/2024. CME credit is not available
	There Might Be a Little Dust on the Bottle: Long-Acting Injectables as a Strategy to Improve Antipsychotic Treatment Adherence Encore Presentation added 07/01/2024. CME credit is available
	Level Up! Using Plasma Levels, Pharmacokinetics, and Pharmacodynamics to Guide Antipsychotic Prescribing Encore Presentation added 04/30/2024. CME credit is available
	Long-Acting Injectable Versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations This Month in Psychpharmacology added 02/29/2024. CME credit is not available
	Get to the Point: Utilizing Long-Acting Injectable Antipsychotics to Improve Adherence and Prevent Relapse Encore Presentation added 12/22/2023. CME credit is available
	This Year in Psychopharmacology: 2023 MPP: Articles added 12/19/2023. CME credit is available
	SMI Among Us: Treating Serious Mental Illness in the Community Encore Presentation added 12/12/2023. CME credit is available
	The Long Haul: Long-Term Use of Antipsychotic Treatment in Schizophrenia Encore Presentation added 12/12/2023. CME credit is available
	Dopamine Partial Agonists: How They Work and Why They Don't Always Play Nice with Other Antipsychotics Encore Presentation added 08/02/2023. CME credit is available
	Give It a Shot: Long-Acting Injectables for Schizophrenia and Bipolar Disorder Encore Presentation added 05/31/2023. CME credit is available
	FDA Approves Slow-Release Long-Acting Injectable of Risperidone This Month in Psychpharmacology added 05/05/2023. CME credit is not available
	FDA Approves Aripiprazole as First Once-Every-2-Months Long-Acting Injectable for Schizophrenia, Bipolar I Disorder This Month in Psychpharmacology added 05/05/2023. CME credit is not available
	High Dose Antipsychotic Polypharmacy and Hospitalization Risk This Month in Psychpharmacology added 04/13/2023. CME credit is not available
	Pragmatic Precision Psychiatry: Utilizing Pharmacokinetics and Pharmacodynamics to Optimize Antipsychotic Treatment Encore Presentation added 03/29/2023. CME credit is available
	Early Use of LAI Antipsychotics for Patient Adherence, Relapse Prevention, and Brain Preservation Encore Presentation added 03/09/2023. CME credit is available
	Talk To Me: Patient Communication in Schizophrenia Encore Presentation added 12/23/2022. CME credit is available
	Highlights from 2022 NEI Congress: Pre-Conference Precision Psychiatry Workshop This Month in Psychpharmacology added 11/03/2022. CME credit is not available
	2022 NEI Congress Young Investigator Poster Competition Winners This Month in Psychpharmacology added 11/02/2022. CME credit is not available
	Prevention Of Substance Use Disorder In Patients With Schizophrenia This Month in Psychpharmacology added 09/16/2022. CME credit is not available
	Bullseye? Emerging Approaches to the Treatment of Schizophrenia Encore Presentation added 06/14/2022. CME credit is not available
	Jeopardy! Long-Acting Injectables Encore Presentation added 06/07/2022. CME credit is not available
	If You Prescribe Antipsychotics, You Must Use Plasma Levels: Here's Why and How Encore Presentation added 04/29/2022. CME credit is not available
	Practical Guide for Converting to a Long-Acting Injectable Antipsychotic MPP: Articles added 04/26/2022. CME credit is not available
	Where We Are and Where We Are Headed: Advancements in the Treatment of Schizophrenia Encore Presentation added 12/10/2021. CME credit is not available
	Wide Racial and Geographic Disparities Found in Clozapine and LAI Prescriptions This Month in Psychpharmacology added 10/29/2021. CME credit is not available
	FDA Approves Drug for Schizophrenia to be Administered at a Six Month Interval This Month in Psychpharmacology added 09/01/2021. CME credit is not available
	Long-Acting Injectable Antipsychotics Cut Suicide Death Risk in Half This Month in Psychpharmacology added 06/01/2021. CME credit is not available
	Let's Get to the Point: Why We Should Include Long-Acting Injectables in the Treatment of Schizophrenia Encore Presentation added 03/24/2021. CME credit is not available
<< Back 1 2 Next >>